Contraindicated (1)bortezomib will enhance the amount or effect of mavacamten by affecting hepatic enzyme CYP2C19 metabolism. Contraindicated. Strong or moderate CYP2C19 inhibitors might enhance mavacamten systemic publicity, resulting in heart failure because of systolic dysfunction. To cut back the chance of dizziness and lightheadedness, rise up gradually when soaring from https://shield-122108.designertoblog.com/58150648/dup-747-fundamentals-explained